Hepatocellular carcinoma classification: Difference between revisions
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) |
||
| Line 15: | Line 15: | ||
**Combined HCC-[[cholangiocarcinoma]] (HCC-CC) | **Combined HCC-[[cholangiocarcinoma]] (HCC-CC) | ||
**[[Lymphoepithelioma]] | **[[Lymphoepithelioma]] | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | |A01= Urinary Tract Infections}} | |||
{{familytree | | | | |,|-|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|-|.| | }} | |||
{{familytree | | | | |!| | | | |!| | | |!| | | |!| | | | |!| | | | | | | | | | }} | |||
{{familytree | | | | C01 | | | C02 | | C03 | | C04 | | | C05 | C01 = [[Fibrolamellar hepatocellular carcinoma|Fibrolamellar carcinoma]] | C02 = [[Undifferentiated]] carcinoma | C03 = [[Prostatitis]] | C04 = Combined HCC-[[cholangiocarcinoma]] (HCC-CC) | C05 = [[Lymphoepithelioma]]}} | |||
{{familytree/end}} | |||
==Staging== | ==Staging== | ||
Revision as of 18:38, 27 December 2017
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma classification On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma classification |
|
Risk calculators and risk factors for Hepatocellular carcinoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
Hepatocellular carcinoma may be classified according to the histological subtypes. The staging of HCC is based on the TNM staging system.
Classification
- Hepatocellular carcinoma may be classified according to the histological subtypes:[1]
- Fibrolamellar carcinoma
- Sarcomatoid HCC
- Undifferentiated carcinoma
- Combined HCC-cholangiocarcinoma (HCC-CC)
- Lymphoepithelioma
| Urinary Tract Infections | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fibrolamellar carcinoma | Undifferentiated carcinoma | Prostatitis | Combined HCC-cholangiocarcinoma (HCC-CC) | Lymphoepithelioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Staging
According to the TNM staging system, there are four stages of hepatocellular carcinoma based on the tumor size, lymph node involvement, and distant metastasis.[2]
Primary tumor
| TX | Primary tumour cannot be assessed |
| T0 | No evidence of primary tumour |
| T1 | A single tumour with no invasion into the blood vessels of the liver |
| T2 | A single tumour with invasion into the blood vessels or multiple tumours, none more than 5 cm in size |
| T3a | Multiple tumours, with any tumour larger than 5 cm |
| T3b | The tumour has grown into either the portal or hepatic vein |
| T4 | The tumour has grown into nearby organs (other than the gallbladder) or the tumour has grown into the layer of tissue that covers the organs in the abdomen (visceral peritoneum) |
Regional lymph node
| NX | Regional lymph nodes cannot be assessed |
| NX | No regional lymph node metastasis |
| NX | Regional lymph node metastasis |
Distance metastasis
| M0 | No distant metastasis |
| M1 | Distant metastasis |
References
- ↑ Shafizadeh N, Kakar S (2013). "Hepatocellular Carcinoma: Histologic Subtypes". Surg Pathol Clin. 6 (2): 367–84. doi:10.1016/j.path.2013.03.007. PMID 26838979.
- ↑ Canadian Cancer Society.http://www.cancer.ca/en/cancer-information/cancer-type/liver/staging/?region=ab